A retrospective study of the efficacy and safety of naldemedine for opioid-induced constipation in thoracic cancer patients.

Hisao ImaiYukiyoshi FujitaEriko HirutaTakashi MasunoShigeki YamazakiHajime TanakaTeruhiko KamiyaMitsuru SandohSatoshi TakeiKazuya AraiHiromi NishibaJunnosuke MogiKyoichi KairaKoichi Minato

Published in: Thoracic cancer (2022)

The efficacy and safety of naldemedine for thoracic cancer patients in clinical practice were comparable with those of prospective studies, which suggest that naldemedine may be effective and feasible for most thoracic cancer patients.

Keyphrases

spinal cord
clinical practice
chronic pain
pain management
high glucose
drug induced
oxidative stress
irritable bowel syndrome
case control